[O8] Oral Session 8"Cell therapy 1"

[O8-2] Combination therapy of chimeric antigen receptor T cell therapy and an HSV-1-based oncolytic virus expressing the tumor antigen for the CAR T cells

^○Mona Alhussein Aboalela^1,2,3, Mohamed Abdelmoneim^1,2, Yoshinori Naoe¹, Patricia SIBAL^1,2, Shigeru Matsumura¹, Hideki Kasuya¹ (1.Cancer Immune Therapy Research Center, Graduate School of Medicine, Nagoya University, Nagoya, Japan, 2.Department of Surgery II, Graduate School of Medicine, Nagoya University, Nagoya, Japan, 3.Medical Microbiology and Immunology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt)